Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
12,095,339
-
Share change
-
-575,980
-
Total reported value
-
$77,284,000
-
Price per share
-
$6.39
-
Number of holders
-
34
-
Value change
-
-$2,891,830
-
Number of buys
-
18
-
Number of sells
-
21
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2016
As of 31 Mar 2016,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,095,339 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, FIRST MANHATTAN CO, UNITED SERVICES AUTOMOBILE ASSOCIATION, CITIGROUP INC, Eqis Capital Management, Inc., Pine River Capital Management L.P., DEUTSCHE BANK AG\, and Invesco Ltd..
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.